Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (SPRY) Investors to a Securities Class Action Deadline on October 5, 2026

New York, New York--(Newsfile Corp. - August 6, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals Inc. ("ARS" or the "Company") (NASDAQ: SPRY) on behalf of investors that purchased or otherwise acquired ARS securities between March 9, 2026 and June 24, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in ARS and have suffered losses, you may CLICK HERE to contact us.